David Dowling

Life sciences, VC and impact investing lawyer @RopesGray, board member of @esela_eu and lecturer at @LSELaw. Tweets in personal capacity

[Alistair Strathern MP @alistrathern]

Yesterday I had the absolute privilege of of being sworn in as our Member of Parliament for Mid Bedfordshire.

Whether you supported me or not this time, I’ll be working hard for you for every day I’m lucky enough to be our MP.

[Hannah Gomersall @hannahgomersall]

This guy took on torrential rain, pessimism (🙋‍♀️), misleading Lib Dem graphs, attempted smears & disenchantment. He’s gonna be a brilliant MP. Never thought I’d see the day rural Beds went red 🌹

[Alistair Strathern MP @alistrathern]

From the bottom of our hearts - thank you. I will not let you down.

[Peter Kyle @peterkyle]

Alistair Strathern, the bookies favourite to win Mid Bedfordshire.

(If you read that phrase on another party’s leaflet you know what to do…🚮)

[David Dowling @DavidWJDowling]

Thrilled to be back in Oxford to present at this week’s academic conference on legal and financial issues in #venturecapital and #privateequity. Thank you to Sarah Paterson, Simon Witney and David Kershaw for letting me be part of the The London School of…https://t.co/pErz4Y396g

[Labour East @EofELabour]

Congratulations to Alistair Strathern, Labour’s candidate for Mid Bedfordshire.

People here have been totally overlooked by a Tory government too busy fighting one another to tackle soaring bills and GP waiting times.

Alistair will put the people of Mid Bedfordshire first.

[David Dowling @DavidWJDowling]

Honoured to have been nominated for #risingstar (#corporate) by LMG Life Sciences together with two other nominations for Ropes & Gray LLP's London #lifesciences team. Thanks to my excellent colleagues Lincoln Tsang, Hannah Kerr-Pe…https://t.co/zDKr9fH4JX https://t.co/57bJKYxPz5

[David Dowling @DavidWJDowling]

British political parties continue to try and woo the #lifescienceindustry and encourage more #innovation and #investment in the UK. This time the Chancellor has released a new #LifeScieforGrowth. While some of the announcements ha…https://t.co/i3StgK3Eud https://t.co/qxQfpdr47E

[David Dowling @DavidWJDowling]

Last month Oliver Hyams and I stepped down as trustees from Pro Bono Community, a charity we founded 10 years ago. We are incredibly proud of everything that the charity has achieved in that time, and there are far too many people…https://t.co/vX6gMzUYF1 https://t.co/VGa7AY4mPE

[David Dowling @DavidWJDowling]

Congratulations to Silvia Cerolini, Enrico Orlandi and all those involved with Eyes on the Future in organising such a fantastic event to highlight and support those affected by #RDH12. #rarediseases #genetherapy https://t.co/KLD0ydnAvs

[David Dowling @DavidWJDowling]

Not all #venturecapitalists and #startupfounders may follow #UKpolitics. However, they should take note, as the Shadow Chancellor (#RachelReeves) continues to try and position the Labour Party as the party of #innovation and #busin…https://t.co/ppHLCDKPmh https://t.co/KXq6AhVaRq

[David Dowling @DavidWJDowling]

Great to chat last week with @christelthunell from Mergermarket about the state of the #healthcare #mergersandacquisitions market. #pharma #lifesciences https://t.co/aA5L1oYmKa

[David Dowling @DavidWJDowling]

As we look ahead to the next general election, the main British political parties continue to compete over the #lifescienceindustry. The Labour Party intends to make the #NHS more pro-#business, with a focus on #clinicaltrials. Alt…https://t.co/srIRw6wj5d https://t.co/JZ2XbW0zwR

[David Dowling @DavidWJDowling]

As many European #biotechs weigh their options for financing, the US continues to be the destination of choice for many #lifesciences companies looking to list. Daniel Forman and I consider why this may be the case, and it what it means for the UK. https://t.co/fmmKdEOgUK

[David Dowling @DavidWJDowling]

It was great to connect with so many people in Basel this week for the #swissbiotechday 2023 - congratulations to Swiss Biotech Association for a fantastic conference. There are a number of interesting takeaways for #dealmakers in…https://t.co/2XNNuthiHt https://t.co/WFuXPiLCNy

[David Dowling @DavidWJDowling]

Congratulations to Michael R Huebner on an interesting presentation yesterday at #swissbiotechday. Great to catch up with colleagues from Johnson & Johnson #lifesciences #biotech https://t.co/EidHCph996

[David Dowling @DavidWJDowling]

Looking forward to #swissbiotechday 2023, and catching up with colleagues working in #biotech, #lifesciences and #healthcare. Thanks to Swiss Biotech Association. It would be great to connect if you are here as well. https://t.co/oHaXAS0KTR

[David Dowling @DavidWJDowling]

Many thanks to WIRED and Robert Reddick for an excellent WIRED Health conference last week. Events such as these are a sign that #healthcare and #lifesciences are moving more into the mainstream of #venturecapital and #impactinvesting. https://t.co/7gw0Id7i6h

[David Dowling @DavidWJDowling]

My colleagues @kellie_combs, Lincoln Tsang and Katherine Wang have authored a chapter on the evolving #regulatory landscape for #digitalhealth across the USA, Europe and China. #lifesciences #artificialintelligence https://t.co/MgbEEeQP18

[David Dowling @DavidWJDowling]

Last week Jeremy Hunt, the UK's Chancellor of the Exchequer, unveiled his "Budget for growth". It is striking how he chose to focus so heavily on #scienceandtechnology, #lifesciences and #innovation. As part of this the #budget2023…https://t.co/b0Wlm9g6f3 https://t.co/UzelhcKO8M